Psoriasis Treating Topicals Made from Cannabinoid Extracts
March 31st saw a couple of patent grants for topical cannabinoid formulations for treating skin conditions including acne and psoriasis.
Patent 10,603,344, assigned to Canopy Growth, is for a topical made from the extract of Futura 75. Grown in the mountains of Italy, Futura 75 hemp is very low in THC with a moderate amount of CBD (~1-3%) making it quite desirable for topical applications. It is claimed to treat dermatological conditions such as acne and psoriasis.
The second patent (US Pat. No. 10,603,301) for a topical cannabinoid formulation comes from Israeli company One World Cannabis. Notably, the patented formulation is made from a 1:1 ratio of THC to CBD and treats inflammatory skin disorders like psoriasis.
Subscribe to Magic Number for unique insights and same day US Patent and Patent Application updates displayed neatly on our Patent Radian diagram.
Related Posts
Cannabis Popularity Soars Along With Tests To Detect It
The Duquenois Levine Test is used in the field by law enforcement officers to test for THC presence in a suspected sample. The problem with…
Hound Labs, Cannabix and Vox Heat Up the Marijuana Breathalyzer Market
At the start of April 2021, Patent Forecast® released an insight going over some of the big name competitors getting their foot in the door…
Driving While High? Cannabis Sobriety Testing Heats Up
What’s the future of cannabis innovation? We see things before they happen using our Patent Forecast®. One of those is the development of…